Deb S, Deb S P
Department of Microbiology, Medical College of Wisconsin, Milwaukee 53226.
Nucleic Acids Res. 1989 Apr 11;17(7):2733-52. doi: 10.1093/nar/17.7.2733.
Using gel retardation assays, we have detected an Ori-S binding activity in the nuclear extract of HSV-1 infected Vero cells. The sequence-specific DNA binding activity seems to be identical to that described by Elias et al. (Proc. Natl. Acad. Sci. USA 83: 6322-6326, 1986). This activity fails to retard a mutant origin DNA that has a 5 bp deletion in the reported protein binding site along with an A to T substitution at a position 16 base-pairs away from the site. This mutant also failed to replicate in a transient replication assay, thus correlating binding of the factor on the origin to replication efficiency. Using crude nuclear extracts as the source of the factor and with the help of footprint and gel retardation analyses, we confirmed that protection is only observed on the preferred site of binding on and near the left arm of the Ori-S palindrome. In order to analyze the sequence specificity of the binding we have generated a set of binding site mutants. Competition experiments with these mutant origins indicate that the sequence 5'-TTCGCACTT-3' is crucial for binding.
利用凝胶阻滞试验,我们在单纯疱疹病毒1型(HSV-1)感染的非洲绿猴肾细胞(Vero细胞)的核提取物中检测到了Ori-S结合活性。这种序列特异性DNA结合活性似乎与Elias等人(《美国国家科学院院刊》83: 6322 - 6326, 1986)所描述的相同。这种活性不能使一个突变的起始DNA发生阻滞,该突变起始DNA在报道的蛋白质结合位点有一个5 bp的缺失,并且在距该位点16个碱基对处有一个A到T的替换。这个突变体在瞬时复制试验中也不能复制,因此将该因子在起始位点上的结合与复制效率联系了起来。以粗核提取物作为该因子的来源,并借助足迹法和凝胶阻滞分析,我们证实只有在Ori-S回文左臂上及其附近的首选结合位点上才能观察到保护作用。为了分析结合的序列特异性,我们构建了一组结合位点突变体。用这些突变起始位点进行的竞争实验表明,序列5'-TTCGCACTT-3'对于结合至关重要。